A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects
This study has been completed.
First Posted: July 6, 2005
Last Update Posted: October 16, 2009
Information provided by: